Lake Street Advisors Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.41M Buy
6,163
+38
+0.6% +$9.15K 0.07% 184
2024
Q3
$1.5M Buy
6,125
+533
+10% +$119K 0.07% 162
2024
Q2
$1.07M Buy
5,592
+4,518
+421% +$917K 0.05% 204
2024
Q1
$213K Buy
+1,074
New +$197K 0.01% 541
2021
Q3
Sell
-6,320
Closed -$1.74M 382
2021
Q2
$1.74M Buy
6,320
+28
+0.4% +$5.89K 0.13% 75
2021
Q1
$1.22M Sell
6,292
-598
-9% -$120K 0.1% 90
2020
Q4
$1.47M Sell
6,890
-1,070
-13% -$213K 0.12% 73
2020
Q3
$1.36M Buy
7,960
+509
+7% +$94K 0.13% 70
2020
Q2
$1.43M Buy
+7,451
New +$1.22M 0.15% 65

Other funds holding RMD

Lake Street Advisors Group's RMD Position: Q4 2024 in Review

Lake Street Advisors Group increased its ResMed (RMD) stake by 0.62% in Q4 2024, buying an estimated $9.15K and bringing the position to 6,163 shares worth $1.41M. The position accounts for 0.07% of the portfolio, ranked #184.

Lake Street Advisors Group first reported a position in RMD in Q2 2020 and has held it in 9 quarters since. The position peaked at $1.74M in Q2 2021. 872 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • Lake Street Advisors Group held 6,163 shares of ResMed worth $1.41M as of Q4 2024.
  • Lake Street Advisors Group bought 38 ResMed shares in Q4 2024, an estimated $9.15K.
  • ResMed made up 0.07% of Lake Street Advisors Group's portfolio in Q4 2024, its #184 holding.
  • Lake Street Advisors Group first reported a position in ResMed in Q2 2020 and has held it in 9 quarters since.
  • Lake Street Advisors Group's ResMed position peaked at $1.74M in Q2 2021.
  • 872 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Lake Street Advisors Group's 13F filing for Q4 2024, filed 4 Feb 2025.